<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Inmunoterapia &#187; Ámbito regulatorio</title>
	<atom:link href="https://temas.sld.cu/inmunoterapia/category/ambito-regulatorio/feed/" rel="self" type="application/rss+xml" />
	<link>https://temas.sld.cu/inmunoterapia</link>
	<description>Sitio web dedicado a la inmunoterapia en Cuba</description>
	<lastBuildDate>Wed, 24 Jan 2024 03:23:02 +0000</lastBuildDate>
	<language>es-ES</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline</title>
		<link>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/</link>
		<comments>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 18:53:40 +0000</pubDate>
		<dc:creator><![CDATA[Raúl Lázaro Castro Almarales]]></dc:creator>
				<category><![CDATA[Ámbito regulatorio]]></category>
		<category><![CDATA[Europa]]></category>
		<category><![CDATA[guías y protocolos]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/inmunoterapia/?p=71</guid>
		<description><![CDATA[Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline V. Gödicke and F. Hundt. Allergy Volume 65, Issue 12, pages 1499–1505, December 2010]]></description>
		<wfw:commentRss>https://temas.sld.cu/inmunoterapia/2011/02/28/registration-trials-for-specific-immunotherapy-in-europe-advanced-guidance-from-the-new-european-medical-agency-guideline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory environment for allergen-specific immunotherapy</title>
		<link>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-environment-for-allergen-specific-immunotherapy/</link>
		<comments>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-environment-for-allergen-specific-immunotherapy/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 18:52:36 +0000</pubDate>
		<dc:creator><![CDATA[Raúl Lázaro Castro Almarales]]></dc:creator>
				<category><![CDATA[Ámbito regulatorio]]></category>
		<category><![CDATA[alérgeno específica]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/inmunoterapia/2011/02/28/regulatory-environment-for-allergen-specific-immunotherapy/</guid>
		<description><![CDATA[Regulatory environment for allergen-specific immunotherapy S. Kaul, S. May, D. Lüttkopf and S. Vieths. Allergy Vol. 66 Issue 3. Published online: 3 FEB 2011]]></description>
		<wfw:commentRss>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-environment-for-allergen-specific-immunotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens</title>
		<link>https://temas.sld.cu/inmunoterapia/2011/02/28/the-consolidated-standards-of-reporting-trials-consort-statement-applied-to-allergen-specific-immunotherapy-with-inhalant-allergens-a-global-allergy-and-asthma-european-network-ga2len-article/</link>
		<comments>https://temas.sld.cu/inmunoterapia/2011/02/28/the-consolidated-standards-of-reporting-trials-consort-statement-applied-to-allergen-specific-immunotherapy-with-inhalant-allergens-a-global-allergy-and-asthma-european-network-ga2len-article/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 18:51:25 +0000</pubDate>
		<dc:creator><![CDATA[Raúl Lázaro Castro Almarales]]></dc:creator>
				<category><![CDATA[Ámbito regulatorio]]></category>
		<category><![CDATA[inhaladores]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/inmunoterapia/?p=67</guid>
		<description><![CDATA[The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article P. J. Bousquet, M.A. Calderón, P.Demoly, D. Larenas, G. Passalacqua, C. Bachert, J. Brozek, G.W. Canonica, T. Casale, J. Fonseca, R. Dahl, S.R. Durham, H. Merk, M. Worm, U. Wahn, T. [&#8230;]]]></description>
		<wfw:commentRss>https://temas.sld.cu/inmunoterapia/2011/02/28/the-consolidated-standards-of-reporting-trials-consort-statement-applied-to-allergen-specific-immunotherapy-with-inhalant-allergens-a-global-allergy-and-asthma-european-network-ga2len-article/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory aspects of specific immunotherapy in Europe</title>
		<link>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-aspects-of-specific-immunotherapy-in-europe/</link>
		<comments>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-aspects-of-specific-immunotherapy-in-europe/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 18:49:55 +0000</pubDate>
		<dc:creator><![CDATA[Raúl Lázaro Castro Almarales]]></dc:creator>
				<category><![CDATA[Ámbito regulatorio]]></category>

		<guid isPermaLink="false">http://articulos.sld.cu/inmunoterapia/?p=65</guid>
		<description><![CDATA[Regulatory aspects of specific immunotherapy in Europe Kaul S; Englert L; May S; Vieths S. Current Opinion in Allergy &#38; Clinical Immunology: December 2010 &#8211; Volume 10 &#8211; Issue 6 &#8211; p 594–602]]></description>
		<wfw:commentRss>https://temas.sld.cu/inmunoterapia/2011/02/28/regulatory-aspects-of-specific-immunotherapy-in-europe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
